AI-Generated Summary

The global protein expression market is projected to reach USD 6.60 billion by 2032, growing at a 7.23% CAGR from its 2024 valuation of USD 3.78 billion. This expansion is fueled by increasing demand for biologics, advancements in synthetic biology, CRISPR, and AI-driven protein engineering, alongside rising R&D investments. While mammalian systems currently dominate, prokaryotic systems are expected to see the fastest growth.

In a nutshell

This market expansion highlights the critical role of protein expression technologies in accelerating drug discovery and development, particularly for biologics and advanced therapies. The insights into system preferences and regional growth provide valuable intelligence for pharmaceutical and biotech companies strategizing R&D investments and market entry.

Source: GlobeNewswire